A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback